22nd Century Group, Inc. (XXII) |
0.7489 0.029 (4%)
|
03-24 16:00 |
Open: |
0.7504 |
Pre. Close: |
0.7201 |
High:
|
0.7999 |
Low:
|
0.745 |
Volume:
|
1,836,023 |
Market Cap:
|
162(M) |
|
|
Technical analysis |
as of: 2023-03-24 4:31:41 PM |
Overall:
|
|
Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
Target: |
Six months: 1.04 One year: 1.16  |
Support: |
Support1: 0.71 Support2: 0.59 |
Resistance: |
Resistance1: 0.89 Resistance2: 1  |
Pivot: |
0.84  |
Moving Average: |
MA(5): 0.79 MA(20): 0.85 
MA(100): 1.02 MA(250): 1.41  |
MACD: |
MACD(12,26): -0.1 Signal(9): -0.1  |
Stochastic oscillator: |
%K(14,3): 6.6 %D(3): 11.9  |
RSI: |
RSI(14): 36  |
52-week: |
High: 2.7 Low: 0.71 |
Average Vol(K): |
3-Month: 1,114 (K) 10-Days: 1,200 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ XXII ] has closed above bottom band by 5.9%. Bollinger Bands are 13.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
0.8 - 0.81 |
0.81 - 0.81 |
Low:
|
0.73 - 0.74 |
0.74 - 0.74 |
Close:
|
0.74 - 0.75 |
0.75 - 0.76 |
|
Company Description |
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York. |
Headline News |
Sat, 25 Mar 2023 Before You Sell 22nd Century Group Inc. (NASDAQ: XXII) Shares ... - Stocks Register
Thu, 23 Mar 2023 Will 22nd Century Group Inc (XXII) Stay at the Bottom of the Healthcare Sector? - InvestorsObserver
Tue, 21 Mar 2023 The -37.92% Simple Moving Average of 22nd Century Group Inc.'s ... - The News Heater
Mon, 13 Mar 2023 22nd Century Group, Inc. (NASDAQ:XXII) Q4 2022 Earnings Call Transcript - Yahoo Finance
Sun, 12 Mar 2023 22nd Century Group (NASDAQ:XXII) Price Target Cut to $3.00 by ... - MarketBeat
Thu, 09 Mar 2023 22nd Century: Q4 Earnings Snapshot - Chron
|
Financial Analysis |
Price to Book Value: |
Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Underperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Underperform |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Underperform |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Neutral |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NASDAQ |
Sector: Consumer Defensive |
Industry: Tobacco |
Shares Out. |
215 (M) |
Shares Float |
213 (M) |
% Held by Insiders
|
2.6 (%) |
% Held by Institutions
|
21.3 (%) |
Shares Short
|
15,970 (K) |
Shares Short P.Month
|
17,110 (K) |
Stock Financials |
EPS
|
-0.15 |
EPS Est Next Qtl
|
-0.02 |
EPS Est This Year
|
-0.11 |
EPS Est Next Year
|
-0.08 |
Book Value (p.s.)
|
0.31 |
Profit Margin (%)
|
-96.7 |
Operating Margin (%)
|
-83.5 |
Return on Assets (ttm)
|
-22.5 |
Return on Equity (ttm)
|
-47.5 |
Qtrly Rev. Growth
|
203.3 |
Gross Profit (p.s.)
|
0 |
Sales Per Share
|
0.22 |
EBITDA (p.s.)
|
-0.18 |
Qtrly Earnings Growth
|
0 |
Operating Cash Flow
|
-37 (M) |
Levered Free Cash Flow
|
-27 (M) |
Stock Valuations |
PE Ratio
|
-5.28 |
PEG Ratio
|
0 |
Price to Book value
|
2.34 |
Price to Sales
|
3.28 |
Price to Cash Flow
|
-4.33 |
Stock Dividends |
Dividend
|
0 |
Forward Dividend
|
0 |
Dividend Yield
|
0% |
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
Your Ad Here
|
|